These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 29434389)

  • 21. Concomitant Administration of a Histamine2 Receptor Antagonist and Proton Pump Inhibitor Enhances Gastric Acid Suppression.
    Abdul-Hussein M; Freeman J; Castell D
    Pharmacotherapy; 2015 Dec; 35(12):1124-9. PubMed ID: 26621819
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of baseline gastrointestinal risk and use of proton pump inhibitors on frequency of discontinuation of aspirin for secondary cardiovascular prevention in United kingdom primary care.
    Martín Merino E; Johansson S; Nagy P; García Rodríguez LA
    Am J Cardiol; 2013 Oct; 112(8):1075-82. PubMed ID: 23831164
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Proton pump inhibitors and hypomagnesemia in the general population: a population-based cohort study.
    Kieboom BC; Kiefte-de Jong JC; Eijgelsheim M; Franco OH; Kuipers EJ; Hofman A; Zietse R; Stricker BH; Hoorn EJ
    Am J Kidney Dis; 2015 Nov; 66(5):775-82. PubMed ID: 26123862
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Feasibility of a pharmacy-led intervention to de-implement non-guideline-concordant proton pump inhibitor use.
    Musuuza JS; Fong E; Lata P; Willenborg K; Knobloch MJ; Hoernke MJ; Spiel AR; Tischendorf JS; Suda KJ; Safdar N
    Implement Sci Commun; 2021 Jun; 2(1):59. PubMed ID: 34074337
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reducing co-administration of proton pump inhibitors and antibiotics using a computerized order entry alert and prospective audit and feedback.
    Kandel CE; Gill S; McCready J; Matelski J; Powis JE
    BMC Infect Dis; 2016 Jul; 16():355. PubMed ID: 27449956
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Randomized controlled trial of transoral incisionless fundoplication vs. proton pump inhibitors for treatment of gastroesophageal reflux disease.
    Witteman BP; Conchillo JM; Rinsma NF; Betzel B; Peeters A; Koek GH; Stassen LP; Bouvy ND
    Am J Gastroenterol; 2015 Apr; 110(4):531-42. PubMed ID: 25823768
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The use of proton pump inhibitors in an Italian hospital: focus on oncologic and critical non-ICU patients.
    Meli M; Raffa MP; Malta R; Morreale I; Aprea L; D'Alessandro N
    Int J Clin Pharm; 2015 Dec; 37(6):1152-61. PubMed ID: 26319396
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Discontinuation of Proton Pump Inhibitors in Patients With Chronic Kidney Disease.
    Mertz A; Cooney D; Rahman M; Lacey C; Burant CJ; Desai N
    Hosp Pharm; 2021 Aug; 56(4):308-313. PubMed ID: 34381266
    [No Abstract]   [Full Text] [Related]  

  • 29. Step-down from multiple- to single-dose proton pump inhibitors (PPIs): a prospective study of patients with heartburn or acid regurgitation completely relieved with PPIs.
    Inadomi JM; McIntyre L; Bernard L; Fendrick AM
    Am J Gastroenterol; 2003 Sep; 98(9):1940-4. PubMed ID: 14499769
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Proton pump inhibitor prescribing patterns in newborns and infants.
    Illueca M; Alemayehu B; Shoetan N; Yang H
    J Pediatr Pharmacol Ther; 2014; 19(4):283-7. PubMed ID: 25762873
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Proton pump inhibitor co-prescription with dual antiplatelet therapy among patients with acute coronary syndrome in Qatar.
    Awaisu A; Hamou F; Mekideche L; El Muabby N; Mahfouz A; Mohammed S; Saad A
    Int J Clin Pharm; 2016 Apr; 38(2):353-61. PubMed ID: 26749343
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The silent epidemic: Inappropriate use of proton pump inhibitors among hospitalized patients.
    Mohamed MR; Itani M; Abohelwa M; Ahmed MA; Abdouni L; Doumat G; Azzo M; Dabdoub F; Al-Tfaili H; Elziny M; Assaf G
    Arab J Gastroenterol; 2024 Nov; 25(4):414-420. PubMed ID: 39069424
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Proton bomb inhibitors: a study of the prescription in a functional recovery unit].
    López-Dóriga Bonnardeaux P; Neira Álvarez M; Mansilla Laguía S
    Rev Esp Geriatr Gerontol; 2013; 48(6):269-71. PubMed ID: 24099902
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A cost-effectiveness analysis of prescribing strategies in the management of gastroesophageal reflux disease.
    Gerson LB; Robbins AS; Garber A; Hornberger J; Triadafilopoulos G
    Am J Gastroenterol; 2000 Feb; 95(2):395-407. PubMed ID: 10685741
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Indication of acid suppression therapy and predictors for the prophylactic use of protonpump inhibitors vs. histamine-2 receptor antagonists in a Malaysian tertiary hospital.
    Oh AL; Tan AG; Phan HS; Lee BC; Jumaat N; Chew SP; Wong SH; Ting SH; Subramaniam T
    Pharm Pract (Granada); 2015; 13(3):633. PubMed ID: 26445624
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nissen fundoplication
    Zhang C; Hu ZW; Yan C; Wu Q; Wu JM; Du X; Liu DG; Luo T; Li F; Wang ZG
    World J Gastroenterol; 2017 May; 23(19):3546-3555. PubMed ID: 28596691
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gastroesophageal reflux disease-related symptom recurrence in patients discontinuing proton pump inhibitors for Bravo
    Schey R; Alla SP; Midani D; Parkman HP
    Rev Gastroenterol Mex; 2017; 82(4):277-286. PubMed ID: 28385467
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Laryngopharyngeal reflux: prospective cohort study evaluating optimal dose of proton-pump inhibitor therapy and pretherapy predictors of response.
    Park W; Hicks DM; Khandwala F; Richter JE; Abelson TI; Milstein C; Vaezi MF
    Laryngoscope; 2005 Jul; 115(7):1230-8. PubMed ID: 15995512
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comparison of aspirin and clopidogrel with or without proton pump inhibitors for the secondary prevention of cardiovascular events in patients at high risk for gastrointestinal bleeding.
    Hsiao FY; Tsai YW; Huang WF; Wen YW; Chen PF; Chang PY; Kuo KN
    Clin Ther; 2009 Sep; 31(9):2038-47. PubMed ID: 19843493
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Proton Pump Inhibitors and the Risk for Hospital-Acquired Clostridium difficile Infection.
    Barletta JF; El-Ibiary SY; Davis LE; Nguyen B; Raney CR
    Mayo Clin Proc; 2013 Oct; 88(10):1085-90. PubMed ID: 24012413
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.